Aptose Biosciences Inc. total revenue, net income and dynamics of changes in US dollar today
Net income Aptose Biosciences Inc. - -16 227 000 $. Information about net income is used from open sources. The dynamics of net income of Aptose Biosciences Inc. has changed by -1 514 000 $ in recent years. These are the main financial indicators of Aptose Biosciences Inc.. Schedule of the financial report of Aptose Biosciences Inc. for today. The financial report chart on our website displays information by dates from 30/06/2017 to 31/03/2021. The value of Aptose Biosciences Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
-16 227 000 $
-
31/12/2020
0 $
-
-14 713 000 $
-
30/09/2020
0 $
-
-13 249 000 $
-
30/06/2020
0 $
-
-15 750 000 $
-
31/03/2019
0 $
-
-5 506 000 $
-
31/12/2018
0 $
-
-6 261 000 $
-
30/09/2018
0 $
-
-5 531 000 $
-
30/06/2018
0 $
-
-10 266 000 $
-
31/03/2018
0 $
-
-6 816 000 $
-
31/12/2017
0 $
-
-2 869 596.33 $
-
30/09/2017
0 $
-
-2 668 214.39 $
-
30/06/2017
0 $
-
-2 492 003.44 $
-
Show:
to
Aptose Biosciences Inc. financial report charts
Dates of Aptose Biosciences Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Aptose Biosciences Inc. is available online for such a date - 31/03/2021. Operating income Aptose Biosciences Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Aptose Biosciences Inc. is -16 252 000 $
Aptose Biosciences Inc. quarterly report dates
Net income Aptose Biosciences Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Aptose Biosciences Inc. is -16 227 000 $ Current assets Aptose Biosciences Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Aptose Biosciences Inc. is 114 144 000 $ Total assets Aptose Biosciences Inc. refers to the total amount of assets owned by a person or entity. Total assets Aptose Biosciences Inc. is 115 195 000 $
Current cash Aptose Biosciences Inc. - the sum of all of the cash a company has on the date of report. Current cash Aptose Biosciences Inc. is 87 083 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-16 252 000 $
-14 759 000 $
-13 294 000 $
-15 881 000 $
-5 600 000 $
-6 325 000 $
-5 611 000 $
-5 329 000 $
-6 842 000 $
-2 888 690.95 $
-2 737 539.60 $
-2 533 524.02 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-16 227 000 $
-14 713 000 $
-13 249 000 $
-15 750 000 $
-5 506 000 $
-6 261 000 $
-5 531 000 $
-10 266 000 $
-6 816 000 $
-2 869 596.33 $
-2 668 214.39 $
-2 492 003.44 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
8 228 000 $
8 969 000 $
7 519 000 $
6 866 000 $
3 340 000 $
4 184 000 $
3 591 000 $
2 818 000 $
-
1 839 605.02 $
1 405 850.73 $
1 124 131.14 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
16 252 000 $
14 759 000 $
13 294 000 $
15 881 000 $
5 600 000 $
6 325 000 $
5 611 000 $
5 329 000 $
6 842 000 $
2 888 690.95 $
2 737 539.60 $
2 533 524.02 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
114 144 000 $
125 076 000 $
133 945 000 $
83 862 000 $
17 664 000 $
16 486 000 $
16 065 000 $
19 057 000 $
16 524 000 $
11 825 000 $
11 064 625.60 $
11 126 745.40 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
115 195 000 $
126 262 000 $
135 258 000 $
85 318 000 $
19 723 000 $
16 870 000 $
16 295 000 $
19 288 000 $
16 674 000 $
11 967 000 $
11 211 337.09 $
11 292 827.70 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
87 083 000 $
117 393 000 $
99 727 000 $
54 112 000 $
16 581 000 $
15 299 000 $
15 056 000 $
17 944 000 $
15 408 000 $
10 631 000 $
7 945 797.36 $
7 917 358.68 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
2 977 000 $
2 789 000 $
2 370 000 $
2 401 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
16 178 000 $
11 429 000 $
10 955 801.15 $
10 896 075.54 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
4 299 000 $
2 789 000 $
2 370 000 $
2 401 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
21.80 %
16.53 %
14.54 %
12.45 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
109 406 000 $
118 915 000 $
129 156 000 $
79 219 000 $
15 424 000 $
14 081 000 $
13 925 000 $
16 887 000 $
14 469 000 $
10 202 000 $
9 876 423.79 $
10 287 107.09 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-4 874 000 $
-5 502 000 $
-4 468 000 $
-9 257 000 $
-4 098 000 $
-2 431 456.10 $
-2 147 469.23 $
-2 745 740.30 $
Last revenue report of Aptose Biosciences Inc. was 31/03/2021. According to last financial report total revenue in Aptose Biosciences Inc. was 0 US dollar and changed by 0% since last year. Net income in Aptose Biosciences Inc. was -16 227 000 $ in last quartal, net income changes to 0%.
Aptose Biosciences Inc. stocks data
APTO stock price
Aptose Biosciences Inc. stock price today, APTO stock quote.
